119 results
Page 5 of 6
424B5
7yd9lp064gofj4qxggs4
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
wrtpu
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
z1ut9nqevn
5 Mar 15
Current report (foreign)
12:00am
6-K
EX-99
091o0w7kn7xb5 7tv
9 Feb 15
2015 Annual General Meeting of Shareholders
12:00am
6-K
EX-99
l5xne4rdg71h1p 0qp
16 Dec 14
Current report (foreign)
12:00am
424B2
0g4nnh9
13 Jun 14
Prospectus for primary offering
12:00am
F-3
trwroa9epy5
30 May 14
Shelf registration (foreign)
12:00am
424B5
c8m21c5i2q g37p9gy
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
hw49hyabdwj0 63
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
lemjhjt8c 89
3 Mar 14
Current report (foreign)
12:00am
6-K
EX-99
mzij3if5j8
21 Jan 14
BioLineRx Receives Approval to Commence
12:00am
6-K
EX-99
jzn7k 7ic
8 Jan 14
Current report (foreign)
12:00am
6-K
EX-99
bcn89h0zel1n
7 Oct 13
BioLineRx Announces Receipt of Notice of Allowance
12:00am
424B3
d8115kz r0l
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
q07htf34dlwx7pctxv1q
29 Jul 13
BioLineRx Announces CE-Mark Registration
12:00am
6-K
EX-99
y2p54 mr9w1qzjhrcm9j
10 Jul 13
2013 Annual General Meeting of Shareholders
12:00am
6-K
EX-99
1iec83tujpzq9k5f
28 Feb 13
Current report (foreign)
12:00am
424B5
kl2 td4c1
6 Feb 13
Prospectus supplement for primary offering
12:00am